Product code MOZ
- Device name
- Acid, Hyaluronic, Intraarticular
- Medical specialty
- Unknown
- Device class
- 3
- Review panel
- OR
- Implant
- N
- Life sustaining/supporting
- N
- GMP exempt
- N
- Third party review
- N
- Summary malfunction reporting
- Eligible
- Source
- FDA openFDA device classification dataset
Related PMA Records#
| PMA | Device | Applicant | Decision date |
|---|---|---|---|
| P080020S055 | GEL-ONE | Seikagaku Corp. | 2026-04-09 |
| P170016S001 | SYNOJOYNT™ | Mesoblast | 2025-12-23 |
| P170007S015 | DUROLANE | Bioventus, LLC | 2025-12-23 |
| P980044S065 | SUPARTZ FX; VISCO-3 | Seikagaku Corp. | 2025-12-19 |
| P010029S042 | EUFLEXXA® (1% SODIUM HYALURONATE) | Ferring Pharmaceuticals, Inc. | 2025-10-16 |
| P980044S064 | SUPARTZ FX | Seikagaku Corp. | 2025-08-18 |
| P980044S063 | SUPARTZ FX; VISCO-3 | Seikagaku Corp. | 2025-07-22 |
| P080020S054 | Gel-One | Seikagaku Corp. | 2025-06-18 |
| P010029S041 | EUFLEXXA (1% SODIUM HYALURONATE) | Ferring Pharmaceuticals, Inc. | 2025-05-28 |
| P160057S003 | TriVisc | Channel-Markers Medical, LLC | 2025-05-20 |
| P140005S006 | GenVisc 850 | Channel-Markers Medical, LLC | 2025-05-20 |
| P150010S005 | HYMOVIS ONE | Fidia Farmaceutici | 2025-04-09 |
| P080020S053 | Gel-One | Seikagaku Corp. | 2025-01-17 |
| P940015S052 | Synvisc, Synvisc-One | Sanofi Genzyme Corp. | 2025-01-02 |
| P150010S004 | HYMOVIS® (High Molecular Weight Viscoelastic Hyaluronan) | Fidia Farmaceutici | 2024-10-16 |
| P010029S040 | EUFLEXXA | Ferring Pharmaceuticals, Inc. | 2024-09-23 |
| P010029S039 | EUFLEXXA | Ferring Pharmaceuticals, Inc. | 2024-08-17 |
| P980044S062 | SUPARTZ FX, VISCO-3 | Seikagaku Corp. | 2024-07-25 |
| P950027S019 | HYALGAN® | Fidia Farmaceutici S.P.A. | 2024-06-28 |
| P180040S005 | TRILURON® | Fidia Farmaceutici S.P.A. | 2024-06-28 |
| P150010S003 | HYMOVIS® | Fidia Farmaceutici | 2024-06-28 |
| P010029S038 | EUFLEXXA | Ferring Pharmaceuticals, Inc. | 2024-04-06 |
| P010029S037 | EUFLEXXA | Ferring Pharmaceuticals, Inc. | 2024-03-01 |
| P010029S036 | EUFLEXXA® (1% sodium hyaluronate) | Ferring Pharmaceuticals, Inc. | 2024-02-02 |
| P110005S014 | Gelsyn-3 | Ibsa Institut Biochimique SA | 2024-01-11 |
| P080020S052 | Gel-One | Seikagaku Corp. | 2023-12-08 |
| P090031S016 | Monovisc | Anika Therapeutics, Inc. | 2023-08-08 |
| P010029S035 | EUFLEXXA | Ferring Pharmaceuticals, Inc. | 2023-06-27 |
| P160057S002 | TriVisc® | Channel-Markers Medical, LLC | 2023-06-22 |
| P140005S005 | GenVisc® 850 | Channel-Markers Medical, LLC | 2023-06-22 |
Related GUDID Devices#
| Primary DI | Brand | Company | Published |
|---|---|---|---|
| 05065026658074 | Synvisc | MAPLESTONE DEVELOPMENTS LIMITED | 2026-03-04 |
| 05065026658043 | Synvisc | MAPLESTONE DEVELOPMENTS LIMITED | 2026-03-04 |
| 05065026658036 | Orthovisc | MAPLESTONE DEVELOPMENTS LIMITED | 2026-03-04 |
| 05065026658029 | Monovisc | MAPLESTONE DEVELOPMENTS LIMITED | 2026-03-04 |
| 05065026658067 | Euflexxa | MAPLESTONE DEVELOPMENTS LIMITED | 2026-03-04 |
| 05065026658005 | Durolane | MAPLESTONE DEVELOPMENTS LIMITED | 2026-03-04 |
| 05065026658050 | Synvisc | MAPLESTONE DEVELOPMENTS LIMITED | 2026-03-04 |
| 05065026658012 | Euflexxa | MAPLESTONE DEVELOPMENTS LIMITED | 2026-03-04 |
| 08052570475131 | Supartz | DAMBO SRL | 2025-11-26 |
| M713FID075010 | HYMOVIS® ONE Professional Sample, 32mg/4ml syringe | FIDIA FARMACEUTICI SPA | 2025-11-07 |
| M713891220750010 | HYMOVIS® ONE 32mg/4ml syringe | FIDIA FARMACEUTICI SPA | 2025-11-07 |
| 08052570473212 | Durolane | DAMBO SRL | 2025-09-25 |
| 08052570473441 | Euflexxa | DAMBO SRL | 2025-09-25 |
| 03770034301165 | Synvisc | UNIVERDERM | 2025-03-13 |
| M713891220879010 | TRILURON | FIDIA FARMACEUTICI SPA | 2024-05-07 |
| 00193493000760 | TriVisc Sodium Hyaluronate | Avanos Medical, Inc. | 2024-03-06 |
| 00193493000753 | GenVisc 850 Sodium Hyaluronate | Avanos Medical, Inc. | 2024-03-06 |
| 05060604130126 | Durolane | ACRE PHARMA LIMITED | 2023-01-12 |
| 00357844181137 | SYNOJOYNT | TEVA PHARMACEUTICALS USA, INC. | 2019-05-08 |
| 00850653006047 | TriVisc™ sodium hyaluronate | Avanos Medical, Inc. | 2018-12-20 |
| 10886705025183 | Monovisc | Anika Therapeutics, Inc. | 2017-05-31 |
| M71389122496630SAM1 | Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe | FIDIA FARMACEUTICI SPA | 2017-02-12 |
| M717715655550 | SUPARTZ® sodium hyaluronate | SEIKAGAKU CORPORATION | 2017-01-31 |
| 00850653006016 | GenVisc® 850 sodium hyaluronate | Avanos Medical, Inc. | 2016-10-31 |
| 05060497630048 | Synvisc | PHARMACEUTICAL HEALTH LIMITED | 2016-10-28 |
| M71389122049663A16 | Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe | FIDIA FARMACEUTICI SPA | 2016-03-21 |
| M71389122496630A16 | Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe | FIDIA FARMACEUTICI SPA | 2015-11-06 |
| 05060459970007 | Synvisc | ALLY MEDICAL SUPPLIES LTD | 2015-10-23 |
| 25060432190006 | SYNVISC | FCL HEALTH SOLUTIONS LTD | 2015-05-26 |
| 10886705023110 | Orthovisc | Anika Therapeutics, Inc. | 2014-08-15 |